US20080199967A1 - System for Detection of S-Nitrosoproteins - Google Patents
System for Detection of S-Nitrosoproteins Download PDFInfo
- Publication number
- US20080199967A1 US20080199967A1 US12/016,094 US1609408A US2008199967A1 US 20080199967 A1 US20080199967 A1 US 20080199967A1 US 1609408 A US1609408 A US 1609408A US 2008199967 A1 US2008199967 A1 US 2008199967A1
- Authority
- US
- United States
- Prior art keywords
- species
- nitrosylated
- fluorescence
- biological sample
- developing agent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 238000001514 detection method Methods 0.000 title description 15
- 238000000034 method Methods 0.000 claims abstract description 68
- 239000012472 biological sample Substances 0.000 claims abstract description 31
- 108091005622 nitrosylated proteins Proteins 0.000 claims abstract description 14
- MWUXSHHQAYIFBG-UHFFFAOYSA-N Nitric oxide Chemical compound O=[N] MWUXSHHQAYIFBG-UHFFFAOYSA-N 0.000 claims description 82
- 108090000623 proteins and genes Proteins 0.000 claims description 43
- 102000004169 proteins and genes Human genes 0.000 claims description 40
- LTYUPYUWXRTNFQ-UHFFFAOYSA-N 5,6-diamino-3',6'-dihydroxyspiro[2-benzofuran-3,9'-xanthene]-1-one Chemical compound C12=CC=C(O)C=C2OC2=CC(O)=CC=C2C11OC(=O)C2=C1C=C(N)C(N)=C2 LTYUPYUWXRTNFQ-UHFFFAOYSA-N 0.000 claims description 26
- 239000003153 chemical reaction reagent Substances 0.000 claims description 26
- 239000003795 chemical substances by application Substances 0.000 claims description 16
- 150000001413 amino acids Chemical class 0.000 claims description 14
- 239000000203 mixture Substances 0.000 claims description 14
- 239000000523 sample Substances 0.000 claims description 14
- 230000005284 excitation Effects 0.000 claims description 11
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 10
- 229910021591 Copper(I) chloride Inorganic materials 0.000 claims description 10
- OXBLHERUFWYNTN-UHFFFAOYSA-M copper(I) chloride Chemical compound [Cu]Cl OXBLHERUFWYNTN-UHFFFAOYSA-M 0.000 claims description 10
- 230000009635 nitrosylation Effects 0.000 claims description 9
- 125000003396 thiol group Chemical group [H]S* 0.000 claims description 9
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 8
- 239000012047 saturated solution Substances 0.000 claims description 8
- 238000000926 separation method Methods 0.000 claims description 7
- 239000007787 solid Substances 0.000 claims description 6
- 229910052717 sulfur Inorganic materials 0.000 claims description 6
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 5
- 229940072107 ascorbate Drugs 0.000 claims description 5
- 235000010323 ascorbic acid Nutrition 0.000 claims description 5
- 239000011668 ascorbic acid Substances 0.000 claims description 5
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims description 5
- 229910052799 carbon Inorganic materials 0.000 claims description 5
- 229910052760 oxygen Inorganic materials 0.000 claims description 5
- 239000001301 oxygen Substances 0.000 claims description 5
- 238000002264 polyacrylamide gel electrophoresis Methods 0.000 claims description 5
- 230000005855 radiation Effects 0.000 claims description 5
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 claims description 4
- 239000002738 chelating agent Substances 0.000 claims description 4
- 210000003527 eukaryotic cell Anatomy 0.000 claims description 4
- 238000001155 isoelectric focusing Methods 0.000 claims description 4
- 210000004962 mammalian cell Anatomy 0.000 claims description 4
- 239000002184 metal Substances 0.000 claims description 4
- 229910052751 metal Inorganic materials 0.000 claims description 4
- 229910052757 nitrogen Inorganic materials 0.000 claims description 4
- VYEUQMVIGXFZQU-UHFFFAOYSA-M potassium 2-(4-carboxylatophenyl)-4,4,5,5-tetramethylimidazoline-1-oxyl-3-oxide Chemical compound [K+].CC1(C)C(C)(C)N([O])C(C=2C=CC(=CC=2)C([O-])=O)=[N+]1[O-] VYEUQMVIGXFZQU-UHFFFAOYSA-M 0.000 claims description 4
- 239000000126 substance Substances 0.000 claims description 4
- 239000011593 sulfur Substances 0.000 claims description 4
- 238000004128 high performance liquid chromatography Methods 0.000 claims description 3
- 239000000463 material Substances 0.000 claims description 3
- 238000004237 preparative chromatography Methods 0.000 claims description 3
- 238000000246 agarose gel electrophoresis Methods 0.000 claims description 2
- FNEZBBILNYNQGC-UHFFFAOYSA-N methyl 2-(3,6-diamino-9h-xanthen-9-yl)benzoate Chemical class COC(=O)C1=CC=CC=C1C1C2=CC=C(N)C=C2OC2=CC(N)=CC=C21 FNEZBBILNYNQGC-UHFFFAOYSA-N 0.000 claims 2
- 201000010099 disease Diseases 0.000 abstract description 6
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 6
- 238000012544 monitoring process Methods 0.000 abstract description 6
- 238000001917 fluorescence detection Methods 0.000 abstract description 4
- 238000011161 development Methods 0.000 abstract description 2
- 229940126585 therapeutic drug Drugs 0.000 abstract description 2
- 238000012216 screening Methods 0.000 abstract 1
- 235000018102 proteins Nutrition 0.000 description 38
- 241000894007 species Species 0.000 description 29
- 239000000499 gel Substances 0.000 description 21
- 238000006243 chemical reaction Methods 0.000 description 14
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 12
- 235000001014 amino acid Nutrition 0.000 description 8
- 150000001875 compounds Chemical class 0.000 description 8
- 210000004027 cell Anatomy 0.000 description 7
- 239000000243 solution Substances 0.000 description 7
- 239000000020 Nitrocellulose Substances 0.000 description 6
- 230000033228 biological regulation Effects 0.000 description 6
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 6
- 235000018417 cysteine Nutrition 0.000 description 6
- 229920001220 nitrocellulos Polymers 0.000 description 6
- 230000035945 sensitivity Effects 0.000 description 6
- 150000003573 thiols Chemical class 0.000 description 6
- 108010088751 Albumins Proteins 0.000 description 5
- 102000009027 Albumins Human genes 0.000 description 5
- 230000005754 cellular signaling Effects 0.000 description 5
- 230000008569 process Effects 0.000 description 5
- 108010005843 Cysteine Proteases Proteins 0.000 description 4
- 102000005927 Cysteine Proteases Human genes 0.000 description 4
- 108010093594 S-nitrosoalbumin Proteins 0.000 description 4
- 230000006295 S-nitrosylation Effects 0.000 description 4
- 238000001502 gel electrophoresis Methods 0.000 description 4
- 239000012528 membrane Substances 0.000 description 4
- 108091006515 Anion channels Proteins 0.000 description 3
- 102000037829 Anion channels Human genes 0.000 description 3
- 102000004190 Enzymes Human genes 0.000 description 3
- 108090000790 Enzymes Proteins 0.000 description 3
- 239000004201 L-cysteine Substances 0.000 description 3
- 235000013878 L-cysteine Nutrition 0.000 description 3
- 239000000872 buffer Substances 0.000 description 3
- 230000001413 cellular effect Effects 0.000 description 3
- 238000004587 chromatography analysis Methods 0.000 description 3
- 230000007123 defense Effects 0.000 description 3
- 238000001962 electrophoresis Methods 0.000 description 3
- 229940088598 enzyme Drugs 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- 230000004962 physiological condition Effects 0.000 description 3
- 238000011002 quantification Methods 0.000 description 3
- 230000005062 synaptic transmission Effects 0.000 description 3
- DYUUGILMVYJEHY-UHFFFAOYSA-N 1-$l^{1}-oxidanyl-4,4,5,5-tetramethyl-3-oxido-2-phenylimidazol-3-ium Chemical compound CC1(C)C(C)(C)N([O])C(C=2C=CC=CC=2)=[N+]1[O-] DYUUGILMVYJEHY-UHFFFAOYSA-N 0.000 description 2
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 2
- 206010029260 Neuroblastoma Diseases 0.000 description 2
- 102000008299 Nitric Oxide Synthase Human genes 0.000 description 2
- 108010021487 Nitric Oxide Synthase Proteins 0.000 description 2
- 239000004365 Protease Substances 0.000 description 2
- HYHSBSXUHZOYLX-WDSKDSINSA-N S-nitrosoglutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CSN=O)C(=O)NCC(O)=O HYHSBSXUHZOYLX-WDSKDSINSA-N 0.000 description 2
- 230000004075 alteration Effects 0.000 description 2
- 238000010420 art technique Methods 0.000 description 2
- 238000003556 assay Methods 0.000 description 2
- 125000004429 atom Chemical group 0.000 description 2
- 102220351054 c.122G>A Human genes 0.000 description 2
- 238000007385 chemical modification Methods 0.000 description 2
- 229910052802 copper Inorganic materials 0.000 description 2
- 239000010949 copper Substances 0.000 description 2
- 230000001186 cumulative effect Effects 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 238000011065 in-situ storage Methods 0.000 description 2
- 238000002955 isolation Methods 0.000 description 2
- 239000011159 matrix material Substances 0.000 description 2
- 238000000386 microscopy Methods 0.000 description 2
- 230000002438 mitochondrial effect Effects 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- 230000000704 physical effect Effects 0.000 description 2
- 108090000765 processed proteins & peptides Proteins 0.000 description 2
- 102000004196 processed proteins & peptides Human genes 0.000 description 2
- 238000000164 protein isolation Methods 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 125000004434 sulfur atom Chemical group 0.000 description 2
- ICRHORQIUXBEPA-UHFFFAOYSA-N thionitrous acid Chemical compound SN=O ICRHORQIUXBEPA-UHFFFAOYSA-N 0.000 description 2
- 238000001262 western blot Methods 0.000 description 2
- LJGMMJRMAAXLPD-DKWTVANSSA-N (2r)-2-amino-3-nitrososulfanylpropanoic acid;copper Chemical compound [Cu].OC(=O)[C@@H](N)CSN=O LJGMMJRMAAXLPD-DKWTVANSSA-N 0.000 description 1
- 102100022089 Acyl-[acyl-carrier-protein] hydrolase Human genes 0.000 description 1
- 229920000936 Agarose Polymers 0.000 description 1
- 102000014914 Carrier Proteins Human genes 0.000 description 1
- 108090000397 Caspase 3 Proteins 0.000 description 1
- 102000003952 Caspase 3 Human genes 0.000 description 1
- 108090000625 Cathepsin K Proteins 0.000 description 1
- 102000004171 Cathepsin K Human genes 0.000 description 1
- 102000001554 Hemoglobins Human genes 0.000 description 1
- 108010054147 Hemoglobins Proteins 0.000 description 1
- 101001066129 Homo sapiens Glyceraldehyde-3-phosphate dehydrogenase Proteins 0.000 description 1
- 241000725303 Human immunodeficiency virus Species 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 108090000526 Papain Proteins 0.000 description 1
- 102000035195 Peptidases Human genes 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 102000004160 Phosphoric Monoester Hydrolases Human genes 0.000 description 1
- 108090000608 Phosphoric Monoester Hydrolases Proteins 0.000 description 1
- 239000004952 Polyamide Substances 0.000 description 1
- 102000001253 Protein Kinase Human genes 0.000 description 1
- XOWVFANEOZMPKG-REOHCLBHSA-N S-nitroso-L-cysteine Chemical compound OC(=O)[C@@H](N)CSN=O XOWVFANEOZMPKG-REOHCLBHSA-N 0.000 description 1
- 108091005623 S-nitrosylated proteins Proteins 0.000 description 1
- 108010071390 Serum Albumin Proteins 0.000 description 1
- 102000007562 Serum Albumin Human genes 0.000 description 1
- 102000019197 Superoxide Dismutase Human genes 0.000 description 1
- 108010012715 Superoxide dismutase Proteins 0.000 description 1
- 102000003978 Tissue Plasminogen Activator Human genes 0.000 description 1
- 108090000373 Tissue Plasminogen Activator Proteins 0.000 description 1
- 102100031988 Tumor necrosis factor ligand superfamily member 6 Human genes 0.000 description 1
- 108050002568 Tumor necrosis factor ligand superfamily member 6 Proteins 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000003466 anti-cipated effect Effects 0.000 description 1
- 230000006907 apoptotic process Effects 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 108091008324 binding proteins Proteins 0.000 description 1
- 230000031018 biological processes and functions Effects 0.000 description 1
- 238000006664 bond formation reaction Methods 0.000 description 1
- 230000001925 catabolic effect Effects 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 239000013592 cell lysate Substances 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 150000001879 copper Chemical class 0.000 description 1
- 230000001086 cytosolic effect Effects 0.000 description 1
- 238000012631 diagnostic technique Methods 0.000 description 1
- BGARROUSYWXSED-UHFFFAOYSA-N dimercury(2+) Chemical compound [Hg+][Hg+] BGARROUSYWXSED-UHFFFAOYSA-N 0.000 description 1
- 150000002019 disulfides Chemical class 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 239000007850 fluorescent dye Substances 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 102000047486 human GAPDH Human genes 0.000 description 1
- 230000002779 inactivation Effects 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 230000005427 lymphocyte apoptotic process Effects 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- 238000000691 measurement method Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 229940100892 mercury compound Drugs 0.000 description 1
- 150000002731 mercury compounds Chemical class 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 238000000329 molecular dynamics simulation Methods 0.000 description 1
- 201000006938 muscular dystrophy Diseases 0.000 description 1
- 238000001426 native polyacrylamide gel electrophoresis Methods 0.000 description 1
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 229940055729 papain Drugs 0.000 description 1
- 235000019834 papain Nutrition 0.000 description 1
- 230000004963 pathophysiological condition Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 230000026731 phosphorylation Effects 0.000 description 1
- 238000006366 phosphorylation reaction Methods 0.000 description 1
- 229920002401 polyacrylamide Polymers 0.000 description 1
- 229920002647 polyamide Polymers 0.000 description 1
- 235000019419 proteases Nutrition 0.000 description 1
- 108060006633 protein kinase Proteins 0.000 description 1
- 230000002797 proteolythic effect Effects 0.000 description 1
- 238000000575 proteomic method Methods 0.000 description 1
- 108020003175 receptors Proteins 0.000 description 1
- 102000005962 receptors Human genes 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 206010039073 rheumatoid arthritis Diseases 0.000 description 1
- 238000012163 sequencing technique Methods 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 125000004354 sulfur functional group Chemical group 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 108091006106 transcriptional activators Proteins 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
Images
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
- G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
- G01N21/631—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited using photolysis and investigating photolysed fragments
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
- G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
- G01N21/64—Fluorescence; Phosphorescence
- G01N21/6447—Fluorescence; Phosphorescence by visual observation
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/17—Nitrogen containing
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/17—Nitrogen containing
- Y10T436/177692—Oxides of nitrogen
Definitions
- Nitric oxide has relatively recently been recognized as a biological messenger that reacts with a variety of sulfhydryl-containing molecules and enzymes to produce S-nitrosylated compounds. Since NO has a short half-life under physiological conditions, it generally exists in biological systems as adducts of amino acids, peptides, and proteins (“NO equivalents”). These NO equivalents are usually biologically active in that they behave as NO donors, and thereby possess unique pharmacological properties.
- the various targets for nitrosylation include serum albumin, tissue-type plasminogen activator, transcriptional activators, glyceraldehyde-3-phosphate dehydrogenase, human immunodeficiency virus protease, hemoglobin, and protein-phosphotyrosine phosphatase.
- Nitrosylation can alter protein conformation, leading to the activation or inactivation of enzymes or receptor proteins. Like phosphorylation, the nitrosylation reaction behaves like a “chemical switch” that allows cells to transmit stimuli from the plasma membrane to the nucleus in a highly regulated manner.
- the functions and processes of nitrosylation are difficult to deconvolute, due to the high number of closely-related kinases, and due to the lack of currently available technology to easily and accurately measure the extent or presence of protein nitrosylation.
- Sulfhydryl groups (—SH, also referred to as “thiol”) are among the most reactive groups found in protein molecules. S-nitrosoproteins, S-nitrosothiols, and protein S-nitrosylation reactions are terms that refer to compounds with linkages through the thiol (—SH) group. These types of compounds play important roles in cell signaling processes such as neurotransmission, anion channel regulation, host defense and gene regulation. The chemical modification of the —SH group in proteins thus has important regulatory implications and can be used as a tool in the discovery of novel therapeutics.
- cysteine proteases such as caspase-3 and cathepsin K have been demonstrated to be inhibited by NO donors.
- Cysteine proteases play important roles in various biological processes. Elevated proteolytic activity of cysteine proteases is associated with many disease conditions, such as muscular dystrophy, inflammation, and rheumatoid arthritis.
- the active sites of cysteine proteases contain a cysteine sulfhydryl group which is highly sensitive to oxidation.
- GSNO S-nitrosoglutathione
- the present invention is directed to a practical electrophoresis-based separation and identification system for cellular nitrosoproteins.
- the detection system meets a recognized need in the art for monitoring of NO in normal states and in disease states, provides a method for identifying and quantifying NO in normal and in disease states, and would facilitate the understanding of these processes for the development of better therapeutic drug species.
- the present invention is directed towards a method for detecting the presence of nitrosylated species in biological samples.
- the biological samples are comprised of amino acid-based species.
- the nitrosylated species are adducts between NO and amino acids, peptides, or proteins.
- the atoms forming the adducts with NO include carbon, nitrogen, sulfur, and oxygen.
- the adduct is between NO and sulfur groups.
- the adduct is a nitrosylated protein.
- the protein is a nitrosothiol, or an “S-nitrosoprotein.”
- the nitrosylated protein is S-nitrosoalbumin.
- the method for detecting the presence of nitrosylated species in a biological sample comprises the steps of contacting the biological sample with developing reagents, exposing the sample to excitation radiation, and detecting the resultant emitted fluorescence.
- the developing reagents comprise a fluorescence-developing agent and a molecular species bearing a reactive moiety capable of transnitrosylation.
- the reactive moiety is a thiol bearing group. More preferably, the molecular species capable of transnitrosylation is cysteine.
- the developing reagents comprise a saturated solution of copper (I) chloride.
- the fluorescent agent is 4,5-diaminofluoroscein.
- the developing reagents are added to the biological sample simultaneously. Alternatively, one or more of the developing reagents are added to the biological sample sequentially. Alternatively or additionally, the method of detecting nitrosylated species involves heating or incubating the biological sample to which the fluorescent-developing agent has been added in the presence of ascorbate and carboxyPTIO.
- the method for detecting nitrosylated species in a biological sample is also capable of quantifying the amount of nitrosylated species in the sample.
- the wavelength of the excitation radiation is about 488 nm.
- the preferred fluorescent emission is monitored at a wavelength of about 530 nm.
- the biological sample comprises a mixture of proteins derived from eukaryotic cells.
- the mixture of proteins is derived from mammalian cells in the absence of metal chelators.
- the method comprises the additional step of transferring the nitrosylated species to a solid support material capable of binding prior to contacting the sample with the developing reagents.
- the preferred solid supports include nitrocellulose, polyamides, and other synthetic membranes capable of binding amino acid-based species.
- the present invention further provides a method of detecting the presence of nitrosylated species in a biological sample comprising one or more amino acid-based species, which involves separating the amino acid-based species in the sample, contacting each of these species with developing reagents, exposing the species to excitation radiation, and detecting the emitted fluorescence.
- the nitrosylated species in the separated sample comprise an adduct between NO and an amino acid-based species.
- the adduct is formed between NO and an atom on the amino acid-based species, including carbon, nitrogen, oxygen and sulfur.
- the preferred adduct is through a sulfur atom. More preferably, the preferred adduct is between NO and a sulfur atom on a protein. Still more preferably, the nitrosylated protein is S-nitrosoalbumin.
- the developing reagents comprise a fluorescence-developing agent and a molecular species bearing a reactive moiety capable of transnitrosylation.
- the reactive moiety on the molecular species is a thiol group. More preferably, the molecular species is cysteine.
- the developing reagents include a saturated solution of copper (I) chloride. More preferably, the fluorescence-developing agent includes 4,5-diaminofluoroscein (DAF-2).
- DAF-2 4,5-diaminofluoroscein
- the developing reagents are added to the biological sample simultaneously. Alternatively, one or more of the developing reagents are added to the biological sample sequentially.
- the method is capable of quantifying the amount of each separated nitrosylated species in the biological sample.
- the method further comprises the additional step of incubating the biological sample and the developing reagent to elevated temperature in the presence of ascorbate and carboxyPTIO.
- the sample is heated to around 37° C.
- the wavelength of the excitation radiation is about 488 nm.
- the fluorescent emission is monitored at about 530 nm.
- the mixture of proteins that are separated prior to detection and quantification are derived from eukaryotic cells. More preferably, the mixture of proteins are derived from mammalian cells in the absence of metal chelators prior to separation and prior to detection and quantification.
- the separation can be achieved by commonly used methods that rely on the characteristic physical properties of the molecules, such as the charge, size, molecular weights, polarity, etc.
- Preferred methods of separation include isoelectric focusing, agarose gel electrophoresis, polyacrylamide gel electrophoresis, HPLC, and preparative chromatography. Most preferred is the method of separation using gel electrophoresis.
- the invention provides the additional step of determining the chemical identity of the individual nitrosylated species in the biological sample.
- kits for detecting nitrosylated species comprising a fluorescence-developing agent and a molecular species bearing a reactive moiety capable of nitrosylation, and optionally containing a saturated solution of copper (I) chloride.
- the kit contains 4,5-diaminofluoroscein (DAF-2).
- DAF-2 4,5-diaminofluoroscein
- the reactive moiety capable of transnitrosylation is cysteine.
- the kit provides the capability of detecting the nitrosylated proteins and identifying the nitrosylated proteins in a sample. Also, preferably, the kit provides the capability of quantifying the amount of nitrosylated species in a biological sample using the kit.
- FIG. 1 shows the fluorescence from 8 nM to 1000 nM of S-nitrosoalbumin (SNOBSA) compared to that of the same concentration of native albumin;
- FIG. 2 shows the fluorescence from 8 nM to 1000 nM of S-nitrosoglutathione (GSNO) compared with that of the same concentration of glutathione;
- FIG. 3 shows the fluorescence of cytoplasmic (Cyto) and mitochondrial (Mito) proteins obtained from undifferentiated (O) or differentiated (D) neuroblastoma cells expressing wild-type (WT) or mutant (G41D) superoxide dismutase.
- the arrows indicate proteins with increased fluorescence in the mitochondrial fraction of cells expressing G41D.
- nitrosoprotein and similar terms encompass any protein that has an —NO group linked through a thiol group, oxygen, carbon, or nitrogen group.
- S-nitrosoproteins, S-nitrosothiols, and protein S-nitrosylation reactions are terms that refer to compounds with linkage through the thiol (—SH) group. These types of compounds play important roles in cell signaling processes such as neurotransmission, anion channel regulation, host defense and gene regulation.
- the present invention addresses a need for a method for identifying and quantifying levels of S-nitrosoproteins, and other NO equivalents, that would be useful in monitoring the levels of NO in normal and in disease states, for facilitating diagnoses, and in developing more selective drugs for the treatment of such disease states.
- the present invention in one embodiment, is directed towards an improved, practical electrophoresis-based separation and identification method for cellular S-nitrosoproteins that allows for the identification of S-nitrosoproteins in general, in addition to the quantification of alterations in S-nitrosoprotein concentration following cell signaling events.
- the preferable method of detection produces a signal that is directly proportional to the concentration of the S-nitrosoprotein.
- Isolated S-nitrosoproteins are generally quite stable. Protein thiol adducts of NO have relatively long half-lives under physiologic conditions as compared to free NO, thus making detection of nitrosothiol adducts possible.
- the source for nitrosoprotein mixtures are typically derived from eukaryotic cells.
- S-nitrosoproteins may be present in virtually all cells
- the cell extracts can be prepared from a specific cell type or tissue of a mammalian species, such as human neuroblastoma cells.
- the complex mixture of proteins is prepared from mammalian cells in the absence of metal chelators.
- the present invention is directed to a method of detecting S-nitrosoproteins in a biological sample containing a mixture of proteins based on the transnitrosylation of nitric oxide to a thiol bearing protein or other macromolecule.
- Fluorescent output from the reaction of 4,5-diaminofluorescein (DAF-2) and nitric oxide is indicative of their presence.
- DAF-2 4,5-diaminofluorescein
- nitric oxide is indicative of their presence.
- DAF-2 has been previously used only to measure nitric oxide produced by nitric oxide synthase in situ.
- DAF-2 is used for an altogether different purpose: that of identifying nitric oxide evolved from endogenous S-nitrosoproteins.
- the detection method in this invention is based on correlating the concentration of the S-nitrosoproteins to the amount of cumulative light output from the product of nitric oxide and DAF-2 following excitation.
- the nitric oxide (NO) is likely generated from transnitrosylation of NO + from the nitrosoproteins to cysteine, followed by homolytic breakdown of S-nitrosocysteine to NO and/or from direct reaction of NO + with DAF-2.
- the present invention offers the additional capabilities of detecting S-nitrosoproteins on membranes following Western blotting, on a PAGE gel, by Western blot using ultraviolet irradiation before or after reaction with DAF-2, and in solution following protein isolation.
- a fluorescence detection system for solutions as opposed to an inverted microscopy setup, is required.
- the method of detecting nitrosoproteins thus comprises the steps of contacting the biological sample of mixed proteins with a developing reagent, exposing the sample to an excitation light source and detecting the emitted fluorescence.
- the developing agent is comprised of 4,5-diaminofluorescein (DAF-2) and L-cysteine (or any other suitable molecule that bears a thiol group capable of a transnitrosylation reaction) in a saturated solution of CuCl.
- the developing reagent comprises 100 mM L-cysteine in a saturated solution of CuCl (pH 6) to which about 2.5 to about 10 ⁇ M DAF-2 is added immediately before the developing reagent is placed in contact with the biological sample.
- Transnitrosylation to cysteine and the reaction with copper augment the sensitivity of S-nitrosoproteins to detection by DAF-2.
- the amount of S-nitrosoproteins present in the sample is determined based on the intensity of the detected fluorescence relative to a standard curve generated from known concentrations of S-nitrosoproteins.
- the method in the present invention involves incubating the proteins at 37° C. with 10-100 ⁇ M DAF-2 in a saturated copper solution containing ascorbate and carboxyPTIO (1-100 nM), or exposed to UV light after incubation with DAF-2.
- the mixture of proteins can then be separated by native polyacrylamide gel electrophoresis.
- the gel is then exposed to a fluorescent light source at an excitation wave length of 488 nm and scanned on a fluorimager at an emission wave length of around 530 nm.
- the scanned gel or nitrocellulose is observed for bands of fluorescence from the reaction of N 2 O 3 and DAF-2.
- the amount of S-nitrosoproteins present in the sample is determined based on the intensity of the detected fluorescence relative to a standard curve generated from known concentrations of S-nitrosoproteins.
- the proteins of the biological sample can be separated based on their charge, molecular weight, size, and/or pH using standard techniques known to those skilled in the art, before the biological sample is contacted with the detection reagent.
- the proteins can be separated using chromatographic techniques (such as HPLC) or by polyacrylamide gel electrophoresis.
- the complex mixture of proteins is separated on a native gel, and the proteins are transferred to a nitrocellulose or other synthetic membrane that is capable of binding proteins before the proteins are contacted with the detection reagent. Transferring the proteins to a solid matrix may enhance the signal generated when the separated proteins are subsequently contacted with the developing reagent and exposed to an excitation light source.
- the developing reagent of the present invention produces a detectable fluorescent signal in the presence of a nitrosoprotein.
- the developing reagent can be added directly to the mixture containing the proteins, or the proteins can first be separated based on their physical properties and optionally fractionated before contact with the developing reagent.
- the surface of the gel (or the surface of the membrane if the proteins were subsequently transferred from the gel to a solid matrix, such as nitrocellulose) is exposed to a thin layer of developing reagent that includes 100 mM L-cysteine in a saturated solution of CuCl, pH 6. DAF-2 (2.5-10 ⁇ M) is then added immediately before contact with the gel. This gel is placed over an emission wavelength filter (at about 515 nm). The gel or nitrocellulose is then exposed to a fluorescent light source (excitation wave length 490 nm) and scanned by a fluorimeter at an emission wave length 515 nM or photographed with a camera.
- a fluorescent light source excitation wave length 490 nm
- the scanned gel or nitrocellulose is observed for bands of fluorescence. Additionally or alternatively, the film in a camera is developed to measure cumulative light output from the reaction of NO and DAF-2.
- the nitrosoproteins identified in the gels can be further characterized by cutting out or otherwise physically isolating the relevant protein bands.
- One skilled in the art will appreciate the technique of preparative chromatography and other similar methods that allow for the isolation of individual proteins from a mixture separated by chromatographic techniques. The individual proteins can then be further analyzed by techniques known in the art, such as microsequencing or by addition of monoclonal antibodies.
- DAF-2 has been used only to measure nitric oxide produced by nitric oxide synthase in situ.
- DAF-2 is employed in a new and direct way which allows identification of nitric oxide evolved from endogenous nitrosylated proteins.
- the reaction with copper in the presence of PTIO increases the sensitivity to detection by DAF-2.
- the technique of the present invention is thus more sensitive and capable of detecting micromolar concentrations, and much simpler than the prior art techniques.
- this invention is capable of the detection of nitrosylated proteins in solution following protein isolation procedures like chromatography.
- a fluorescence detection system for solutions as opposed to an inverted microscopy setup (used for analysis of S-nitrosylated proteins on gels) would be required.
- the invention also allows for the isolation of individual proteins by cutting or otherwise removing fluorescent bands from gels and sequencing and identifying the nitrosylated proteins in cell lysates as shown in FIG. 3 .
- the invention may also be used with 2-dimensional gels for proteomic analysis.
- Two specific improvements over the prior art of this technique include the increased sensitivity for identifying very low concentrations of endogenous nitrosylated proteins and improved signal-to-noise ratio on the gels.
- Increasing the sensitivity and improving the signal-to-noise ratio requires variations in the volumes and concentrations of DAF-2 solution, UV light administration, buffer compositions, and timing of application.
- the assay sensitivity will be increased if buffers are developed in which DAF-2 fluorescent intensity is maximized.
- the resolution in measuring nitrosylated proteins from other “background” proteins can achieved by varying gel compositions, thickness, electrophoresis voltages, and buffers.
- FIG. 1 shows fluorescence from 100 ⁇ m S-nitrosoalbumin (Lanes 1 and 2) compared with that of the same concentration of native albumin (Lane 3).
- native albumin is endogenously S-nitrosylated to a limited extent.
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Hematology (AREA)
- Chemical & Material Sciences (AREA)
- Urology & Nephrology (AREA)
- Physics & Mathematics (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Biophysics (AREA)
- Analytical Chemistry (AREA)
- Biotechnology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Microbiology (AREA)
- Bioinformatics & Computational Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Cell Biology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
- Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Abstract
The present invention describes a novel, simplified method for detecting and monitoring the presence of nitrosylated proteins, such as S-nitrosoproteins, in a biological sample using fluorescence detection. The present invention further describes a method which can both quantify and identify the nature of nitrosylated proteins, which method is useful for monitoring both normal and disease states, in the development and screening of potential therapeutic drug species.
Description
- This application is a continuation of U.S. patent application Ser. No. 10/319,457, filed on Dec. 12, 2002, now U.S. Pat. No. ______, which claims the benefit of U.S. Provisional Application No. 60/339,268, filed on Dec. 12, 2001. The entire contents of the foregoing are hereby incorporated by reference.
- This invention was made with United States Government support under Grant Nos. 1RO1 HL59337, HL10026 and GM57601-01, awarded by the national Institute of Health. The United States Government has certain rights in the invention.
- Nitric oxide (NO) has relatively recently been recognized as a biological messenger that reacts with a variety of sulfhydryl-containing molecules and enzymes to produce S-nitrosylated compounds. Since NO has a short half-life under physiological conditions, it generally exists in biological systems as adducts of amino acids, peptides, and proteins (“NO equivalents”). These NO equivalents are usually biologically active in that they behave as NO donors, and thereby possess unique pharmacological properties. The various targets for nitrosylation include serum albumin, tissue-type plasminogen activator, transcriptional activators, glyceraldehyde-3-phosphate dehydrogenase, human immunodeficiency virus protease, hemoglobin, and protein-phosphotyrosine phosphatase.
- Nitrosylation can alter protein conformation, leading to the activation or inactivation of enzymes or receptor proteins. Like phosphorylation, the nitrosylation reaction behaves like a “chemical switch” that allows cells to transmit stimuli from the plasma membrane to the nucleus in a highly regulated manner. However, the functions and processes of nitrosylation are difficult to deconvolute, due to the high number of closely-related kinases, and due to the lack of currently available technology to easily and accurately measure the extent or presence of protein nitrosylation.
- Sulfhydryl groups (—SH, also referred to as “thiol”) are among the most reactive groups found in protein molecules. S-nitrosoproteins, S-nitrosothiols, and protein S-nitrosylation reactions are terms that refer to compounds with linkages through the thiol (—SH) group. These types of compounds play important roles in cell signaling processes such as neurotransmission, anion channel regulation, host defense and gene regulation. The chemical modification of the —SH group in proteins thus has important regulatory implications and can be used as a tool in the discovery of novel therapeutics.
- Chemical modification of thiol groups occurs physiologically via oxidation reactions yielding either mixed disulfides or S-nitrosylated compounds. Alternatively, modification can occur through persulfide and trisulfide bond formation. The “S-nitrosylation” of proteins refers to the transfer of nitric oxide (NO) to sulfhydryl groups on proteins.
- By way of example, some cysteine proteases such as caspase-3 and cathepsin K have been demonstrated to be inhibited by NO donors. (See Wang, Peng et al., Inhibition of Papain by S-Nitrosothiols, J. of Biol. Chem., 275, 2000 pp 20467-20473). Cysteine proteases play important roles in various biological processes. Elevated proteolytic activity of cysteine proteases is associated with many disease conditions, such as muscular dystrophy, inflammation, and rheumatoid arthritis. The active sites of cysteine proteases contain a cysteine sulfhydryl group which is highly sensitive to oxidation.
- Compounds such as S-nitrosoglutathione (GSNO) are relevant biological molecules involved in nitrosylation reactions under physiological conditions. These compounds are also known to fluoresce, which would theoretically make their detection facile in samples derived from biological systems. However, identification of S-nitrosoproteins and measurement of their concentration following certain cellular events has proven to be extraordinarily cumbersome, thus extremely limiting its potential utility.
- In light of the significant physiological implications of NO levels, it would be useful to have a diagnostic technique that can readily detect levels of NO or NO equivalents, such as S-nitrosothiols and other nitrosylated NO equivalents, to determine whether levels are normal for normal physiological conditions, or whether a patient has an existing or predisposition towards a pathophysiological condition. There is a particular need for procedures that are affordable and manageable, yet sensitive enough to detect levels of NO, or NO-adducts such as S-nitrosothiols. (See Beckman, J. S. et al., Methods in Nitric Oxide Research, Feelisch and Stainler, Wiley, Chichester, U.K., 1996; U.S. Pat. No. 5,891,735 to Stamler).
- Representative of prior art approaches to monitoring of nitrosylation, U.S. Pat. No. 5,459,076 to Stamler et al. (incorporated herein by reference) describes a detection method that requires pretreatment with mercurous ion and a protein-precipitating agent. The samples are then monitored by chemiluminescence. This method involves cumbersome pretreatment procedures with a toxic mercury compound and, thus, presents considerable difficulties in application. It would be useful to have a simple procedure with minimal manipulation and without the use of additional chemicals.
- The present invention is directed to a practical electrophoresis-based separation and identification system for cellular nitrosoproteins. The detection system meets a recognized need in the art for monitoring of NO in normal states and in disease states, provides a method for identifying and quantifying NO in normal and in disease states, and would facilitate the understanding of these processes for the development of better therapeutic drug species.
- The present invention is directed towards a method for detecting the presence of nitrosylated species in biological samples. In a preferred embodiment, the biological samples are comprised of amino acid-based species. Preferably, the nitrosylated species are adducts between NO and amino acids, peptides, or proteins. The atoms forming the adducts with NO include carbon, nitrogen, sulfur, and oxygen. Preferably, the adduct is between NO and sulfur groups. More preferably, the adduct is a nitrosylated protein. Still more preferably, the protein is a nitrosothiol, or an “S-nitrosoprotein.” Still more preferably, the nitrosylated protein is S-nitrosoalbumin.
- In an embodiment of the invention, the method for detecting the presence of nitrosylated species in a biological sample comprises the steps of contacting the biological sample with developing reagents, exposing the sample to excitation radiation, and detecting the resultant emitted fluorescence.
- In a preferred embodiment, the developing reagents comprise a fluorescence-developing agent and a molecular species bearing a reactive moiety capable of transnitrosylation. Preferably, the reactive moiety is a thiol bearing group. More preferably, the molecular species capable of transnitrosylation is cysteine.
- In yet another embodiment, the developing reagents comprise a saturated solution of copper (I) chloride. In still another embodiment, the fluorescent agent is 4,5-diaminofluoroscein. In a preferred embodiment, the developing reagents are added to the biological sample simultaneously. Alternatively, one or more of the developing reagents are added to the biological sample sequentially. Alternatively or additionally, the method of detecting nitrosylated species involves heating or incubating the biological sample to which the fluorescent-developing agent has been added in the presence of ascorbate and carboxyPTIO.
- In another embodiment, the method for detecting nitrosylated species in a biological sample is also capable of quantifying the amount of nitrosylated species in the sample.
- In the present invention, the wavelength of the excitation radiation is about 488 nm. The preferred fluorescent emission is monitored at a wavelength of about 530 nm.
- In still another embodiment, the biological sample comprises a mixture of proteins derived from eukaryotic cells. Preferably, the mixture of proteins is derived from mammalian cells in the absence of metal chelators.
- In another embodiment, the method comprises the additional step of transferring the nitrosylated species to a solid support material capable of binding prior to contacting the sample with the developing reagents. The preferred solid supports include nitrocellulose, polyamides, and other synthetic membranes capable of binding amino acid-based species.
- The present invention further provides a method of detecting the presence of nitrosylated species in a biological sample comprising one or more amino acid-based species, which involves separating the amino acid-based species in the sample, contacting each of these species with developing reagents, exposing the species to excitation radiation, and detecting the emitted fluorescence.
- The nitrosylated species in the separated sample comprise an adduct between NO and an amino acid-based species. The adduct is formed between NO and an atom on the amino acid-based species, including carbon, nitrogen, oxygen and sulfur. The preferred adduct is through a sulfur atom. More preferably, the preferred adduct is between NO and a sulfur atom on a protein. Still more preferably, the nitrosylated protein is S-nitrosoalbumin.
- In a preferred embodiment, the developing reagents comprise a fluorescence-developing agent and a molecular species bearing a reactive moiety capable of transnitrosylation. Preferably, the reactive moiety on the molecular species is a thiol group. More preferably, the molecular species is cysteine.
- In another embodiment, the developing reagents include a saturated solution of copper (I) chloride. More preferably, the fluorescence-developing agent includes 4,5-diaminofluoroscein (DAF-2). Preferably, the developing reagents are added to the biological sample simultaneously. Alternatively, one or more of the developing reagents are added to the biological sample sequentially.
- In another embodiment, the method is capable of quantifying the amount of each separated nitrosylated species in the biological sample.
- The method further comprises the additional step of incubating the biological sample and the developing reagent to elevated temperature in the presence of ascorbate and carboxyPTIO. Preferably, the sample is heated to around 37° C.
- Preferably, the wavelength of the excitation radiation is about 488 nm. Also, the fluorescent emission is monitored at about 530 nm.
- Preferably, the mixture of proteins that are separated prior to detection and quantification are derived from eukaryotic cells. More preferably, the mixture of proteins are derived from mammalian cells in the absence of metal chelators prior to separation and prior to detection and quantification. The separation can be achieved by commonly used methods that rely on the characteristic physical properties of the molecules, such as the charge, size, molecular weights, polarity, etc. Preferred methods of separation include isoelectric focusing, agarose gel electrophoresis, polyacrylamide gel electrophoresis, HPLC, and preparative chromatography. Most preferred is the method of separation using gel electrophoresis.
- The invention provides the additional step of determining the chemical identity of the individual nitrosylated species in the biological sample.
- Another aspect of the invention is the capability of providing a kit for detecting nitrosylated species comprising a fluorescence-developing agent and a molecular species bearing a reactive moiety capable of nitrosylation, and optionally containing a saturated solution of copper (I) chloride. Preferably, the kit contains 4,5-diaminofluoroscein (DAF-2). Also, preferably, the reactive moiety capable of transnitrosylation is cysteine.
- Preferably, the kit provides the capability of detecting the nitrosylated proteins and identifying the nitrosylated proteins in a sample. Also, preferably, the kit provides the capability of quantifying the amount of nitrosylated species in a biological sample using the kit.
-
FIG. 1 shows the fluorescence from 8 nM to 1000 nM of S-nitrosoalbumin (SNOBSA) compared to that of the same concentration of native albumin; -
FIG. 2 shows the fluorescence from 8 nM to 1000 nM of S-nitrosoglutathione (GSNO) compared with that of the same concentration of glutathione; and -
FIG. 3 shows the fluorescence of cytoplasmic (Cyto) and mitochondrial (Mito) proteins obtained from undifferentiated (O) or differentiated (D) neuroblastoma cells expressing wild-type (WT) or mutant (G41D) superoxide dismutase. The arrows indicate proteins with increased fluorescence in the mitochondrial fraction of cells expressing G41D. - As used herein, “nitrosoprotein” and similar terms encompass any protein that has an —NO group linked through a thiol group, oxygen, carbon, or nitrogen group. S-nitrosoproteins, S-nitrosothiols, and protein S-nitrosylation reactions are terms that refer to compounds with linkage through the thiol (—SH) group. These types of compounds play important roles in cell signaling processes such as neurotransmission, anion channel regulation, host defense and gene regulation.
- Although a burgeoning number of articles describe a role for S-nitrosoproteins and protein S-nitrosylation reactions in cell signaling processes such as neurotransmission, anion channel regulation, host defense and gene regulation, the detection of nitrosoproteins has been met with limited success. An important implication is in the FAS induced denitrosylation of Capase-3, which allows lymphocyte apoptosis to proceed. (See Mannick J B, et al. Fas-induced capsase denitrosylation. Science 1999, 284: 65.) A method for determining alterations in S-nitrosoprotein concentration following cell signaling events such as the FAS-ligand binding would provide a mechanism for monitoring the progression of apoptosis. The present invention addresses a need for a method for identifying and quantifying levels of S-nitrosoproteins, and other NO equivalents, that would be useful in monitoring the levels of NO in normal and in disease states, for facilitating diagnoses, and in developing more selective drugs for the treatment of such disease states.
- The present invention, in one embodiment, is directed towards an improved, practical electrophoresis-based separation and identification method for cellular S-nitrosoproteins that allows for the identification of S-nitrosoproteins in general, in addition to the quantification of alterations in S-nitrosoprotein concentration following cell signaling events. The preferable method of detection produces a signal that is directly proportional to the concentration of the S-nitrosoprotein.
- Isolated S-nitrosoproteins (in the absence of catabolic enzymes) are generally quite stable. Protein thiol adducts of NO have relatively long half-lives under physiologic conditions as compared to free NO, thus making detection of nitrosothiol adducts possible.
- For the present invention, the source for nitrosoprotein mixtures are typically derived from eukaryotic cells. Though S-nitrosoproteins may be present in virtually all cells, the cell extracts can be prepared from a specific cell type or tissue of a mammalian species, such as human neuroblastoma cells. In accordance with a preferred embodiment of the present invention, the complex mixture of proteins is prepared from mammalian cells in the absence of metal chelators.
- The present invention is directed to a method of detecting S-nitrosoproteins in a biological sample containing a mixture of proteins based on the transnitrosylation of nitric oxide to a thiol bearing protein or other macromolecule. Fluorescent output from the reaction of 4,5-diaminofluorescein (DAF-2) and nitric oxide is indicative of their presence. By measuring the fluorescence from the reaction, a quantitative measurement of S-nitrosoproteins can also be obtained.
- DAF-2 has been previously used only to measure nitric oxide produced by nitric oxide synthase in situ. In accordance with the present invention, DAF-2 is used for an altogether different purpose: that of identifying nitric oxide evolved from endogenous S-nitrosoproteins. The detection method in this invention is based on correlating the concentration of the S-nitrosoproteins to the amount of cumulative light output from the product of nitric oxide and DAF-2 following excitation. The nitric oxide (NO) is likely generated from transnitrosylation of NO+ from the nitrosoproteins to cysteine, followed by homolytic breakdown of S-nitrosocysteine to NO and/or from direct reaction of NO+ with DAF-2.
- The use of S-nitrosocysteine-copper NO evolution as a measurement technique for S-nitrosothiols has been recently reported, (see Fang K, et al., Reductive Assays for S-nitrosothiols: Implications for measurements in biological systems. Biochem Biophys Res Commun 1998; 252:535-540) however, this technique has not previously been used in conjunction with fluorescence detection or with gel electrophoresis. No previous technique has been successful in identifying S-nitrosoproteins by gel electrophoresis. The present invention addresses the need in the art for a practical system of identifying S-nitrosoproteins by gel electrophoresis. Moreover, the present invention offers the additional capabilities of detecting S-nitrosoproteins on membranes following Western blotting, on a PAGE gel, by Western blot using ultraviolet irradiation before or after reaction with DAF-2, and in solution following protein isolation. In the case of solutions, a fluorescence detection system for solutions, as opposed to an inverted microscopy setup, is required.
- The method of detecting nitrosoproteins thus comprises the steps of contacting the biological sample of mixed proteins with a developing reagent, exposing the sample to an excitation light source and detecting the emitted fluorescence. In accordance with one embodiment, the developing agent is comprised of 4,5-diaminofluorescein (DAF-2) and L-cysteine (or any other suitable molecule that bears a thiol group capable of a transnitrosylation reaction) in a saturated solution of CuCl. More particularly, the developing reagent comprises 100 mM L-cysteine in a saturated solution of CuCl (pH 6) to which about 2.5 to about 10 μM DAF-2 is added immediately before the developing reagent is placed in contact with the biological sample. Transnitrosylation to cysteine and the reaction with copper augment the sensitivity of S-nitrosoproteins to detection by DAF-2. In this embodiment, the amount of S-nitrosoproteins present in the sample is determined based on the intensity of the detected fluorescence relative to a standard curve generated from known concentrations of S-nitrosoproteins.
- Alternatively, the method in the present invention involves incubating the proteins at 37° C. with 10-100 μM DAF-2 in a saturated copper solution containing ascorbate and carboxyPTIO (1-100 nM), or exposed to UV light after incubation with DAF-2. The mixture of proteins can then be separated by native polyacrylamide gel electrophoresis. The gel is then exposed to a fluorescent light source at an excitation wave length of 488 nm and scanned on a fluorimager at an emission wave length of around 530 nm. The scanned gel or nitrocellulose is observed for bands of fluorescence from the reaction of N2O3 and DAF-2. In this embodiment, the amount of S-nitrosoproteins present in the sample is determined based on the intensity of the detected fluorescence relative to a standard curve generated from known concentrations of S-nitrosoproteins.
- The proteins of the biological sample can be separated based on their charge, molecular weight, size, and/or pH using standard techniques known to those skilled in the art, before the biological sample is contacted with the detection reagent. For example, the proteins can be separated using chromatographic techniques (such as HPLC) or by polyacrylamide gel electrophoresis. In one embodiment, the complex mixture of proteins is separated on a native gel, and the proteins are transferred to a nitrocellulose or other synthetic membrane that is capable of binding proteins before the proteins are contacted with the detection reagent. Transferring the proteins to a solid matrix may enhance the signal generated when the separated proteins are subsequently contacted with the developing reagent and exposed to an excitation light source.
- The developing reagent of the present invention produces a detectable fluorescent signal in the presence of a nitrosoprotein. The developing reagent can be added directly to the mixture containing the proteins, or the proteins can first be separated based on their physical properties and optionally fractionated before contact with the developing reagent.
- When the proteins have been separated by agarose, isoelectric focusing or polyacrylamide gel electrophoresis, the surface of the gel (or the surface of the membrane if the proteins were subsequently transferred from the gel to a solid matrix, such as nitrocellulose) is exposed to a thin layer of developing reagent that includes 100 mM L-cysteine in a saturated solution of CuCl, pH 6. DAF-2 (2.5-10 μM) is then added immediately before contact with the gel. This gel is placed over an emission wavelength filter (at about 515 nm). The gel or nitrocellulose is then exposed to a fluorescent light source (excitation wave length 490 nm) and scanned by a fluorimeter at an emission wave length 515 nM or photographed with a camera.
- The scanned gel or nitrocellulose is observed for bands of fluorescence. Additionally or alternatively, the film in a camera is developed to measure cumulative light output from the reaction of NO and DAF-2.
- In accordance with one embodiment, the nitrosoproteins identified in the gels (based on the emitted fluorescence) can be further characterized by cutting out or otherwise physically isolating the relevant protein bands. One skilled in the art will appreciate the technique of preparative chromatography and other similar methods that allow for the isolation of individual proteins from a mixture separated by chromatographic techniques. The individual proteins can then be further analyzed by techniques known in the art, such as microsequencing or by addition of monoclonal antibodies.
- This invention represents an improvement on several currently available prior art techniques. First, in the prior art, DAF-2 has been used only to measure nitric oxide produced by nitric oxide synthase in situ. Here, however, DAF-2 is employed in a new and direct way which allows identification of nitric oxide evolved from endogenous nitrosylated proteins. The reaction with copper in the presence of PTIO increases the sensitivity to detection by DAF-2. The technique of the present invention is thus more sensitive and capable of detecting micromolar concentrations, and much simpler than the prior art techniques.
- Additionally, this invention is capable of the detection of nitrosylated proteins in solution following protein isolation procedures like chromatography. A fluorescence detection system for solutions, as opposed to an inverted microscopy setup (used for analysis of S-nitrosylated proteins on gels) would be required. The invention also allows for the isolation of individual proteins by cutting or otherwise removing fluorescent bands from gels and sequencing and identifying the nitrosylated proteins in cell lysates as shown in
FIG. 3 . The invention may also be used with 2-dimensional gels for proteomic analysis. - Two specific improvements over the prior art of this technique include the increased sensitivity for identifying very low concentrations of endogenous nitrosylated proteins and improved signal-to-noise ratio on the gels. Increasing the sensitivity and improving the signal-to-noise ratio requires variations in the volumes and concentrations of DAF-2 solution, UV light administration, buffer compositions, and timing of application. For instance, the assay sensitivity will be increased if buffers are developed in which DAF-2 fluorescent intensity is maximized. Additionally, or alternatively, the resolution in measuring nitrosylated proteins from other “background” proteins can achieved by varying gel compositions, thickness, electrophoresis voltages, and buffers. For instance, the stability of S-nitrosoproteins is enhanced when run on isoelectric focusing gels as opposed to polyacrylamide gels. Finally, it is anticipated that additional known fluorescent probes such as dihydrorhodamine-derivatives can be used in the context of the present invention to increase the specificity and sensitivity of the claimed method.
- Various concentrations of S-nitrosylated albumin or unmodified albumin were incubated with 3 μM DAF-2 for 15 minutes at 37° C. An equal volume of 100 μM CuCl, 1 μM ascorbate and 100 nM PTIO was then added to each sample and the sample was incubated for another 15 minutes at 37° C. The samples were then loaded onto a 12% nondenaturing, nonreducing gel and run for 30 minutes at 30 volts. The gel was placed on a Molecular Dynamics STORM 860 fluorescent Scanner and exposed to an excitation wavelength of 480 nM. The scanner detects all emissions greater than 520 nM. The scanned gel in the figure had been incubated in the presence of CuCl/cys for 1 hour and 20 minutes at the time of scanning.
-
FIG. 1 shows fluorescence from 100 μm S-nitrosoalbumin (Lanes 1 and 2) compared with that of the same concentration of native albumin (Lane 3). Of note, native albumin is endogenously S-nitrosylated to a limited extent.
Claims (22)
1. A method for detecting the presence of nitrosylated species in a biological sample comprising one or more amino acid-based species, the method comprising the steps of:
(a) separating the amino acid-based species in the sample;
(b) contacting the separated species with developing reagents comprising a fluorescence-developing agent that produces a detectable signal in the presence of nitric oxide;
(c) contacting the separated species with a molecular species bearing a thiol moiety capable of transnitrosylation;
(d) exposing the separated species to excitation radiation; and
(e) detecting emitted fluorescence from the fluorescence-developing agent, wherein the emitted fluorescence indicates the presence of a nitrosylated species in the sample.
2. The method of claim 1 , wherein the nitrosylated species comprises an adduct between NO and an amino acid-based species, and wherein the adduct is formed between NO and an atom on the amino acid-based species selected from the group consisting of sulfur, oxygen, nitrogen and carbon.
3. The method of claim 2 , wherein the adduct comprises a nitrosylated protein.
4. The method of claim 1 , wherein the fluorescence-developing agent comprises a dihydrorhodamine derivative.
5. The method of claim 1 , wherein the developing reagents further comprise a saturated solution of copper (I) chloride.
6. The method of claim 1 , wherein the fluorescence-developing agent comprises 4,5-diaminofluoroscein (DAF-2).
7. The method of claim 1 wherein the method is further capable of quantitating an amount of nitrosylated species detected in the biological sample.
8. The method of claim 1 , wherein the method comprises the additional step of incubating the separated species to which has been added the fluorescence-developing agent at an elevated temperature, in the presence of ascorbate and 2-(4-carboxyphenyl)-4,4,5,5-tetramethylimidazolin-1-oxyl 3-oxide (carboxyPTIO).
9. The method of claim 1 , wherein the biological sample is derived from mammalian cells in the absence of metal chelators.
10. The method of claim 1 , wherein the method comprises the additional step of transferring the separated species to a solid support material capable of binding the species, prior to contacting the species with the developing reagents.
11. The method of claim 1 , wherein the nitrosylated species comprises an adduct between NO and an amino acid-based species, and wherein the adduct forms between NO and an atom on the amino acid-based species selected from the group consisting of sulfur, oxygen, nitrogen and carbon.
12. The method of claim 11 , wherein the adduct comprises a nitrosylated protein.
13. The method of claim 1 , wherein the method is further capable of quantifying an amount of nitrosylated species detected in the biological sample.
14. The method of claim 1 , wherein the biological sample comprises a mixture of proteins derived from eukaryotic cells.
15. The method of claim 1 , wherein the method comprises the additional step of transferring the separated species to a solid support material capable of binding the species, prior to contacting the species with the developing reagents.
16. The method of claim 1 , wherein the separation is achieved by a method selected from the group consisting of agarose gel electrophoresis, polyacrylamide gel electrophoresis, isoelectric focusing, High Performance Liquid Chromatography (HPLC), and preparative chromatography.
17. The method of claim 1 , wherein the method comprises the additional step of determining the chemical identity of one or more individual nitrosylated species from the biological sample.
18. A kit for detecting nitrosylated species in a biological sample, the kit comprising a fluorescence-developing agent that produces a detectable signal in the presence of nitric oxide, a molecular species bearing a thiol moiety capable of nitrosylation, and a saturated solution of copper (I) chloride.
19. A method for identifying nitrosylated species in a biological sample using the kit of claim 18 .
20. A method for quantifying the amount of nitrosylated species in a biological sample using the kit of claim 18 .
21. The kit of claim 18 , wherein the fluorescence-developing agent comprises a dihydrorhodamine derivative.
22. The kit of claim 18 , wherein the fluorescence-developing agent comprises 4,5-diaminofluoroscein (DAF-2).
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US12/016,094 US20080199967A1 (en) | 2001-12-12 | 2008-01-17 | System for Detection of S-Nitrosoproteins |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US33926801P | 2001-12-12 | 2001-12-12 | |
US10/319,457 US7419834B2 (en) | 2001-12-12 | 2002-12-12 | System for detection of nitrosylated proteins |
US12/016,094 US20080199967A1 (en) | 2001-12-12 | 2008-01-17 | System for Detection of S-Nitrosoproteins |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US10/319,457 Continuation US7419834B2 (en) | 2001-12-12 | 2002-12-12 | System for detection of nitrosylated proteins |
Publications (1)
Publication Number | Publication Date |
---|---|
US20080199967A1 true US20080199967A1 (en) | 2008-08-21 |
Family
ID=33134718
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US10/319,457 Expired - Fee Related US7419834B2 (en) | 2001-12-12 | 2002-12-12 | System for detection of nitrosylated proteins |
US12/016,094 Abandoned US20080199967A1 (en) | 2001-12-12 | 2008-01-17 | System for Detection of S-Nitrosoproteins |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US10/319,457 Expired - Fee Related US7419834B2 (en) | 2001-12-12 | 2002-12-12 | System for detection of nitrosylated proteins |
Country Status (1)
Country | Link |
---|---|
US (2) | US7419834B2 (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2005081622A1 (en) * | 2004-02-17 | 2005-09-09 | Pharmacia & Upjohn Company Llc | Methods and compositions for the detection of nitric oxide |
US7763472B2 (en) * | 2004-06-16 | 2010-07-27 | University Of Virginia Patent Foundation | Methods for identifying and measuring S-nitrosothiol bonds in heme-containing cells and molecules |
CN101893634B (en) * | 2009-05-20 | 2013-08-28 | 中国科学院生物物理研究所 | Specific detection method of protein or polypeptide cysteine sulfydryl modification and application thereof |
WO2010141719A2 (en) * | 2009-06-03 | 2010-12-09 | University Of Florida Research Foundation Inc. | Materials and methods for measuring nitric oxide levels in a biological fluid |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5459076A (en) * | 1992-04-22 | 1995-10-17 | Brigham And Women's Hospital | Method for detecting nitric oxide, nitrosonium equivalents, S-nitrosothiols and S-nitroso-proteins in biological systems |
US5891735A (en) * | 1995-09-15 | 1999-04-06 | Duke University Medical Center | Method for measuring nitric oxide in nitrosyl (FeII)-hemoglobin and S-nitrosohemoglobin |
-
2002
- 2002-12-12 US US10/319,457 patent/US7419834B2/en not_active Expired - Fee Related
-
2008
- 2008-01-17 US US12/016,094 patent/US20080199967A1/en not_active Abandoned
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5459076A (en) * | 1992-04-22 | 1995-10-17 | Brigham And Women's Hospital | Method for detecting nitric oxide, nitrosonium equivalents, S-nitrosothiols and S-nitroso-proteins in biological systems |
US5891735A (en) * | 1995-09-15 | 1999-04-06 | Duke University Medical Center | Method for measuring nitric oxide in nitrosyl (FeII)-hemoglobin and S-nitrosohemoglobin |
Also Published As
Publication number | Publication date |
---|---|
US7419834B2 (en) | 2008-09-02 |
US20040203068A1 (en) | 2004-10-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101893634B (en) | Specific detection method of protein or polypeptide cysteine sulfydryl modification and application thereof | |
Keusgen | Biosensors: new approaches in drug discovery | |
Eaton | Protein thiol oxidation in health and disease: techniques for measuring disulfides and related modifications in complex protein mixtures | |
Pihlasalo et al. | Method for estimation of protein isoelectric point | |
Torta et al. | Proteomic analysis of protein S‐nitrosylation | |
Li et al. | Improved identification and relative quantification of sites of peptide and protein oxidation for hydroxyl radical footprinting | |
Tim et al. | Ultratrace analysis of drugs in biological fluids using affinity probe capillary electrophoresis: analysis of dorzolamide with fluorescently labeled carbonic anhydrase | |
JPH1025299A (en) | Aligned peptide, and detection of bound/interaction site in protein using the same | |
Suzuki et al. | Construction of a more sensitive fluorescence sensing material for the detection of vascular endothelial growth factor, a biomarker for angiogenesis, prepared by combining a fluorescent peptide and a nanopillar substrate | |
Zhang et al. | Method development and validation of capillary sodium dodecyl sulfate gel electrophoresis for the characterization of a monoclonal antibody | |
US20080199967A1 (en) | System for Detection of S-Nitrosoproteins | |
Randall et al. | Approaches to the analysis of peptides | |
Lausch et al. | Analysis of immunoglobulin G using a capillary electrophoretic affinity assay with protein A and laser‐induced fluorescence detection | |
Liu et al. | Affinity capillary electrophoresis applied to the studies of interactions of a member of heat shock protein family with an immunosuppressant | |
Arakawa et al. | Biophysical and biochemical analysis of recombinant proteins | |
Meng et al. | Moving affinity boundary electrophoresis and its selective isolation of histidine in urine | |
US6299747B1 (en) | Capillary electrophoretic methods to detect new biologically active compounds in complex biological material | |
Grochocki et al. | Different detection and stacking techniques in capillary electrophoresis for metabolomics | |
EP1101114A2 (en) | Method of protein analysis | |
Lim et al. | Miniaturized amperometric flow immunoassay system using a glass fiber membrane modified with anion | |
Wang et al. | Simultaneous monitoring of quantum dots and their assembly and disassembly with PreScission protease using capillary electrophoresis with fluorescence detection | |
Lundblad | The evolution from protein chemistry to proteomics: basic science to clinical application | |
Liu et al. | Characterization of membrane-associated glycoproteins using lectin affinity chromatography and mass spectrometry | |
Omali et al. | Quantification of protein deposits on silicone hydrogel materials using stable-isotopic labeling and multiple reaction monitoring | |
Paton et al. | Investigations into charge heterogeneity of wool intermediate filament proteins |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF Free format text: CONFIRMATORY LICENSE;ASSIGNOR:UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL;REEL/FRAME:021039/0354 Effective date: 20080118 |
|
AS | Assignment |
Owner name: UNIVERSITY OF MASSACHUSETTS, MASSACHUSETTS Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:MANNICK, JOAN;REEL/FRAME:021116/0367 Effective date: 20071229 |
|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |